Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$1.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| Jul 1 | AGIO | Agios Pharmaceuticals,… | MEXER◷◆ | 8,375 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 4,007 | $37.56 | $150.5K | -4.5% | Open the original filing on SEC.gov |
| Jul 1 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 8,375 | — | — | +10.4% | Open the original filing on SEC.gov |
| Jun 18 | AGIO | Agios Pharmaceuticals,… | AGRANT◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | AGIO | Agios Pharmaceuticals,… | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷◆ | 8,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | SSELL◷ | 2,940 | $34.71 | $102K | -3.5% | Open the original filing on SEC.gov |
| Apr 2 | AGIO | Agios Pharmaceuticals,… | MEXER◷ | 8,500 | — | — | +11.4% | Open the original filing on SEC.gov |